Amsterdam, April 27, 2021 – Modra Pharmaceuticals (“Modra”) today announced the appointment of Hemanshu Shah, Ph.D., MBA and Klaus Sch...
-
Modra Pharmaceuticals Appoints Two New Supervisory Board Members Adding Significant Experience in Corporate and Clinical Development
27 April, 2021
-
Modra Pharmaceuticals Presents Preliminary Data from Phase IIb Trial of ModraDoc006/r in Metastatic Prostate Cancer at 2021 ASCO GU Annual Meeting
12 February, 2021
-
ModraDoc006/Ritonavir Offers Promising Therapeutic Option for mCRPC
11 February, 2021